Previous close | 86.00 |
Open | 86.00 |
Bid | 97.50 |
Ask | 106.00 |
Strike | 320.00 |
Expiry date | 2024-06-21 |
Day's range | 86.00 - 86.00 |
Contract range | N/A |
Volume | |
Open interest | 20 |
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...
Insightful Analysis of Vertex Pharmaceuticals' Financials and Strategic Positioning